Page 36 - Vitro Diagnostics News Today

Culture Media Market COVID 19 Impact & In-Depth Analysis till 2025 Facto Market Insights as of late distributed statistical surveying report on the worldwide Culture Media Market to its assortment of statistical surveying reports. BriefingWire.com, 4/27/2021 - Facto Market Insights as of late distributed statistical surveying report on the worldwide Culture Media Market to its assortment of statistical surveying reports. The exploration report co...

Vitro Diagnostics, Inc.: Vitro Biopharma Inc. January 31st 2021, 1st Quarter ended Financial Results of Operations and Shareholder Letter st, 2021, financial results of operations. Vitro Biopharma recorded quarter ended January 31 st, 2021 revenues of $ 127,492 vs $225,921 a decrease of 44% over the prior comparative quarter directly attributed to the COVID-19 pandemic. Revenues in the first quarter of 2021 of $127,492 were down 21% over the $161,888 recorded in the prior fourth quarter. The de...

Share this article Share this article ResearchAndMarkets.coms offering. Hepatitis C Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on Hepatitis C Tests market for the year 2020 and beyond. Hepatitis C is a viral infection caused by hepatitis C virus (HCV). Hepatitis C virus is a blood borne virus th...

European Society of Cardiology Today medical societies will put forward the case for more robust, evidence-based EU health policies during a meeting of the European Parliament’s Science and Technology Options Assessment Panel 1. 2, the European Society of Cardiology 3, the European Hematology Association 4 and the European Federation of Clinical Chemistry and Laboratory Medicine 5 will contribute to an online workshop with the European Commission and Members of the European Parliament. The ev...

Share this article Share this article RICHMOND, Calif., April 22, 2021 /PRNewswire/ -- DiaCarta Inc., a precision molecular diagnostics company and leading developer of novel oncology tests using liquid biopsy today announced the publication of a study entitled "A Rapid SARS-CoV-2 Variant Detection by Molecular-Clamping Based RT-qPCR" in MedRxiV (https://doi.org/10.1101/2021.04.01.21254484) that demonstrates the enhanced sensitivity and specificity using its proprietary XNA based Molecular Cl...

Share this article Share this article ResearchAndMarkets.coms offering. The market has just gotten started with a handful of small startup companies. Expect the big players to start taking notice. CRISPR is not just about changing genes. CRISPR identifies unique genetic material instantly, accurately and cheaply. A whole new world of identification and diagnostics opens up. Find out exactly what kind of cold or flu you have. Find out exactly what kind of fish you are eating. Instantly detect th...

Share this article Share this article ResearchAndMarkets.coms offering. The scope of this study is global. The research analyzes each market and its applications, regulatory environment, technologies involved, market projections and market shares. The emerging markets discussed include countries such as India, China, Korea, Taiwan, Africa, Australia, Brazil and Russia, among others. The report also examines IVD market drivers, as well as restraints and challenges affecting its growth. Further, ...

Press release content from Business Wire. The AP news staff was not involved in its creation. Outlook on the In Vitro Diagnostics Global Market to 2025 - Rapid Technological Developments Expected to Drive Growth - ResearchAndMarkets.com April 15, 2021 GMT DUBLIN--(BUSINESS WIRE)--Apr 15, 2021-- ADVERTISEMENT The scope of this study is global. The research analyzes each market and its applications, regulatory environment, technologies involved, market projections and market shares. The emerging ...

Share this article Share this article ResearchAndMarkets.coms offering. The fertility test market is projected to reach USD 680 Million by 2025 from USD 472 Million in 2020, at a CAGR of 7.5% the forecast period. Growth in this market is primarily driven by the increasing first-time pregnancy age in women, declining fertility rate among men and women, growing number of women suffering from disorders such as PCOS, emergence of advanced ovulation monitors, and the increased awareness of fertilit...

Share: New York, April 09, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Hematology Analyzers (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)" - https://www.reportlinker.com/p05948860/?utm_source=GNW The model discusses in detail the impact of COVID-19 on Hematology Analyzers market for the year 2020 and beyond. Hematology analyzers are used in routine complete blood count analysis, reticulocyte count analysis, and t...